Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Oct 2018)

Molecular Atlas of Postnatal Mouse Heart Development

  • Virpi Talman,
  • Jaakko Teppo,
  • Päivi Pöhö,
  • Parisa Movahedi,
  • Anu Vaikkinen,
  • S. Tuuli Karhu,
  • Kajetan Trošt,
  • Tommi Suvitaival,
  • Jukka Heikkonen,
  • Tapio Pahikkala,
  • Tapio Kotiaho,
  • Risto Kostiainen,
  • Markku Varjosalo,
  • Heikki Ruskoaho

DOI
https://doi.org/10.1161/JAHA.118.010378
Journal volume & issue
Vol. 7, no. 20

Abstract

Read online

Background The molecular mechanisms mediating postnatal loss of cardiac regeneration in mammals are not fully understood. We aimed to provide an integrated resource of mRNA, protein, and metabolite changes in the neonatal heart for identification of metabolism‐related mechanisms associated with cardiac regeneration. Methods and Results Mouse ventricular tissue samples taken on postnatal day 1 (P01), P04, P09, and P23 were analyzed with RNA sequencing and global proteomics and metabolomics. Gene ontology analysis, KEGG pathway analysis, and fuzzy c‐means clustering were used to identify up‐ or downregulated biological processes and metabolic pathways on all 3 levels, and Ingenuity pathway analysis (Qiagen) was used to identify upstream regulators. Differential expression was observed for 8547 mRNAs and for 1199 of 2285 quantified proteins. Furthermore, 151 metabolites with significant changes were identified. Differentially regulated metabolic pathways include branched chain amino acid degradation (upregulated at P23), fatty acid metabolism (upregulated at P04 and P09; downregulated at P23) as well as the HMGCS (HMG‐CoA [hydroxymethylglutaryl‐coenzyme A] synthase)–mediated mevalonate pathway and ketogenesis (transiently activated). Pharmacological inhibition of HMGCS in primary neonatal cardiomyocytes reduced the percentage of BrdU‐positive cardiomyocytes, providing evidence that the mevalonate and ketogenesis routes may participate in regulating the cardiomyocyte cell cycle. Conclusions This study is the first systems‐level resource combining data from genomewide transcriptomics with global quantitative proteomics and untargeted metabolomics analyses in the mouse heart throughout the early postnatal period. These integrated data of molecular changes associated with the loss of cardiac regeneration may open up new possibilities for the development of regenerative therapies.

Keywords